This therapy uses strong magnetic fields to force muscle contractions far beyond voluntary effort, working muscle without exercise. Its best-supported use is strengthening the pelvic floor to ease bladder-control problems. Claims of building abdominal muscle and trimming fat are contested and largely manufacturer-linked. It appears very safe — best seen as a promising add-on, not a substitute for exercise. (Full Review)

Protocol

Body Protocol

4 × 30-min sessions

Over ~2 weeks, twice weekly, ramping to full (100%) intensity

Pelvic Floor (Chair)

6 × ~28-min sessions

Over 3 weeks, twice weekly, seated and fully clothed

Configuration

Match to goal

HIFEM alone for muscle; add radiofrequency for fat; pair with pelvic floor training or resistance exercise

Time to effect

Peak Effect

~3 months

Effects peak around three months after a course

Measured Change

2–4 weeks

Visible or measured change after finishing a course

First Tightening

Within days

Some tightening may be felt early on

Benefits

High: Pelvic floor strengthening & urinary continence

Medium: Increased abdominal & core muscle thickness; localized subcutaneous fat reduction

Low: Improved core muscular endurance & body composition; musculoskeletal function, stiffness & mobility; improved female sexual function

Speculative: Muscle mass preservation against age-related muscle loss; metabolic health & insulin sensitivity

Contraindications

Metallic implants in the treatment area

Cardiac pacemakers or implantable defibrillators

Other active electronic implants

Pregnancy (abdominal or pelvic treatment)

Metal intrauterine device or pelvic metal implants (chair use)

Active malignancy in the treatment field

Hemorrhagic (bleeding) disorders

Recent abdominal or pelvic surgery (within 3–6 months)

Significant untreated hernia at the treatment site

Key Interactions

Blood thinners (warfarin, apixaban), monitor for bruising

Other energy-based treatments in the same area on the same day, space sessions

Risk & Side Effects

High: Transient muscle soreness

Medium: Intramuscular cramping or spasm during sessions; temporary redness, warmth, or swelling

Low: Localized muscle fatigue and tenderness

Speculative: Muscle injury from supramaximal overload; unknown long-term effects of repeated sessions

Monitoring

Marker	Target	Why
Skeletal muscle / lean mass (DEXA)	Upper-normal lean mass for age and sex	Tracks whether sessions preserve or build muscle
Body fat percentage	~10–20% (men), ~18–28% (women)	Gauges body-composition change
Waist circumference	<94 cm (men), <80 cm (women)	Marker of central fat over a treated abdomen
Grip strength (hand dynamometer)	>40 kg (men), >27 kg (women)	Whole-body strength and longevity proxy
Creatine kinase (CK)	~30–200 U/L	Flags excessive muscle breakdown
Continence / pad-weight test (Emsella use)	Pad weight near 0 g; lower symptom score is better	Objective continence outcome

Cadence: Baseline, end of course (~4 weeks), 3 months, then every 6–12 months during maintenance

Qualitative Assessment

Core stability and posture during daily activities
Ease and confidence with bladder control (pelvic application)
Energy and perceived strength in the treated area
Mobility, comfort, and range of motion

HIFEM Therapy for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment